New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...

Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.